Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1223-2020Class II

Terumo AZUR Peripheral Coil System, Detachable 35, Helical HydroCoil Embolization System, REF numbers...

Terumo Cardiovascular Systems Corporation / initiated 2019-11-24 / Terminated

Microvention, Inc. began a recall of Terumo AZUR Peripheral Coil System, Detachable 35, Helical HydroCoil Embolization System, REF numbers 45-451015, 45-451020, 45-451215, 45-451220, 45-451230... on . FDA classified it as Class II and gives the reason as "The devices may be missing the implant coil". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1223-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Terumo Cardiovascular Systems Corporation
Product
Terumo AZUR Peripheral Coil System, Detachable 35, Helical HydroCoil Embolization System, REF numbers 45-451015, 45-451020, 45-451215, 45-451220, 45-451230, 45-451520, 45-451530, 45-452020, 45-452030, 45-450410, 45-450415, 45-450405, 45-450610, 45-450615, 45-450620, 45-450815, 45-450820, and MV-AZ52030HD, Sterile, Rx. The firm name on the label is MicroVention, Inc., Tustin, CA; Distributed By: Terumo Medical Corporation, Somerset, NJ; Made in Costa Rica.
Product code
KRD Device, Vascular, For Promoting Embolization
Reason for recall
The devices may be missing the implant coil.
FDA root cause
Other
Action
The recalling firm issued emails dated 11/24/2019 to the Terumo distributors and provided instructions for notification of their customers (physicians).
Quantity in commerce
392 units
Distribution
The devices were distributed to Maryland. There was no direct military/government distribution. Foreign distribution was made direct to Belgium, Japan, Australia, Argentina, and Mexico.
Product codes and lots
Catalog/lot numbers:   45-451015 - 190410589;   45-451020- 19030456J, 19041056C, 19041756Y, 190422549, and 190422573;  45-451215 -190410569;   45-451220 -19040853N;   45-451230 -19041554R;   45-451520 -19030654N, 190408565, 190410588, and 190422572;  45-451530 -19030456L, 190408569, 19041056A, 190415571, 19041756Z, 190417599, 19042656G, and 19050254X;  45-452020 -19030456N, 19030654L, 19030655W, 19040856A, and 19041552H;  45-452030 - 19041058A, 19041554U, and 19042656H;  45-450410 - 19030456C, 19030655V, 19041058F, and 190422575;  45-450415 - 190422574;   45-450405 - 19030453C, 19030456B, and 19042254B;  45-450610 - 19030456E, 19030654W, 190410568, and 19041058E;  45-450615 - 19030456F, 190401568, 19041058C, and 19041556Y;  45-450620 - 19030453J and 19030655N;  45-450815 - 19030456G, 19030654U, 19050253U, and 19050254Z;  45-450820 - 19030453K,19030456H, 19030654R, 19030655G, 19030655H, 19050253V, 19050254Y, 19050657T, and 19051058C; and   MV-AZ52030HD - 190405564.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1223-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1220-2020Class IITerminatedVoluntary: Firm initiated
Z-1221-2020Class IITerminatedVoluntary: Firm initiated
Z-1222-2020Class IITerminatedVoluntary: Firm initiated
Z-1223-2020Class IITerminatedVoluntary: Firm initiated
Z-1224-2020Class IITerminatedVoluntary: Firm initiated
Z-1225-2020Class IITerminatedVoluntary: Firm initiated